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Background: Pressure ulcers are costly to the healthcare provider and can have a major impact on patient’s quality
of life. One of the most distressing symptoms reported is pain. There is very little published data on the prevalence
and details of pain experienced by patients with pressure ulcers, particularly in community populations. The study
was conducted in two community NHS sites in the North of England.
Methods: The aim was to estimate the prevalence of pressure area related pain within a community population. We
also explored the type and severity of the pain and its association with pressure ulcer classification. A cross-sectional
survey was performed of community nurses caseloads to identify adult patients with pressure ulcers and associated
pain. Consenting patients then had a full pain assessment and verification of pressure ulcer grade.
Results: A total of 287 patients were identified with pressure ulcers (0.51 per 1000 adult population). Of the 176
patients who were asked, 133 (75.6%) reported pain. 37 patients consented to a detailed pain assessment. Painful
pressure ulcers of all grades and on nearly all body sites were identified. Pain intensity was not related to number or
severity of pressure ulcer. Both inflammatory and neuropathic pain were reported at all body sites however the
proportion of neuropathic pain was greater in pressure ulcers on lower limbs.
Conclusions: This study has identified the extent and type of pain suffered by community patients with pressure
ulcers and indicates the need for systematic and regular pain assessment and treatment.
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A pressure ulcer (PU) is described as a “localised injury
to the skin and/or underlying tissue usually over a bony
prominence, as a result of pressure, or pressure in
combination with shear. A number of contributing or
confounding factors are also associated with pressure
ulcers; the significance of these factors is yet to be
elucidated” [1].
PUs are categorised according to the level of tissue
damage. Although many different grading scales exist,
an international classification was published in 2009 [1]
and includes Category 1 as non-blanching erythema of
intact skin, Category 2 as [2] partial thickness dermal
loss or blister, Category 3 as full thickness dermal loss
with or without a cavity or slough, Category 4 as full* Correspondence: Elizabeth.mcginnis@nhs.net
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reproduction in any medium, provided the orthickness dermal loss exposing underlying structures
such as muscle, tendon or bone. Pressure ulcers most
commonly occur when a person is bedfast, chairfast or
spend most of their time in a bed or chair [3]. Body sites
where PUs usually occur are bony prominences such as
the sacrum, ischeal tuberosities, hips and heels [4] where
there is little soft tissue, in particular subcutaneous fat,
to provide padding.
Systematic review evidence indicates that pressure
ulcers result in significant suffering and morbidity to
patients [5]. They are costly to the healthcare provider
and in the UK costs to the health and social care system
are estimated as £1.77 billion per year [6] and a significant
burden to healthcare organisation internationally [2,7].
Patients with PUs are found in all healthcare settings;
reports of prevalence and incidence rates vary according to
the case mix of the population, the study design and the
classification scales used. A review by Garcia [8] identifiedal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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incidence or prevalence of PUs in home care settings.
Incidence rates cited from data base reviews range from
4.5% in Japan [9] to 6.3% in the USA [10], the range of
prevalence was 1.3% in the USA [11] to 19.1% in Brazil
[12]. Prevalence in UK populations has found to range from
0.74/1000 population [13] to 0.51/1000 population [14].
The impacts of PUs on patients include pain, depression,
local infection, osteomyelitis, anaemia, sepsis, gangrene
and death [15]. In a systematic review of the quality of life
(QOL) literature Gorecki et al. [5] identified that pain was
reported by patients as their most troublesome symptom
impacting on QOL. A second systematic review by Gorecki
et al. [16] aimed to understand the nature of PU pain and
map causal pathways from the patients’ perspective. The
review identified that PU pain can be debilitating, reducing
the individual’s ability to participate in physical and social
activities, assume comfortable positions, move, walk, and
undergo rehabilitation [16]. People with PUs describe their
experience as “endless pain” characterised by constant
presence, needing to keep still and describing pain due to
equipment and treatments [5,17].
Experience of local pain or discomfort at a potential
PU body site may also be a precursor to pressure damage
and patients have reported that in their view it was a
precursor to PU development [5]. A number of cohort
studies have assessed the relationship of potential risk
factors to PU development and key variables have
emerged including mobility, factors affecting tissue
perfusion and skin condition [18]. The assessment of
“skin condition” requires clinicians to recognise certain
skin changes which may be indicative of pressure damage
e.g. local indurations, oedema, localised pain and warmth
[19]. These skin change indicators are especially important
for people with darkly pigmented skin where non
blanching erythema may be missed [20] Although
patients are known to report pain, this does not always
prompt action and many healthcare professionals dismiss
patients’ reports of pain [5,16,21]. This lack of recognition
and attention to PU pain may be attributed, in part,
to the fact that the role of pain in PU development and
treatment is poorly understood by health professionals.
Reviews of the epidemiological literature carried out
by Girouard et al. 2008 and Pieper et al. [8,22] identify
eight studies reporting the prevalence of pain associated
with PUs (sample sizes from 20 to 186 patients) , in hospital,
community and palliative care settings. PU pain prevalence
estimates were 37% and 66% in the two largest studies with
more than 100 patients. Limitations in the literature include
the use of non-validated measures of pain (including nurse
assessed pain outcomes), small sample sizes, and an absence
of studies which report the dominant type of pain. There
are essentially two types of pain: nociceptive pain resulting
from the inflammatory response, and neuropathic painoccurring as a result of nerve damage or tissue ischaemia
[23]. Understanding the characteristics of pain is important
as successful pain management depends upon using
interventions which address the cause(s) of the pain.
A further problem with research in the field is that pain
reports are often limited to Category 2 and above PUs
[5,8,16,22]. Pain associated with Category 1 PUs is not
reported in most studies, nor is the presence of pain
on ‘pressure areas’ despite patient reports that pain at
‘pressure areas’ preceded PU development [5].
In summary, qualitative evidence identifies pain as an
important issue for patients preceding PU development
and in PU management. Previous epidemiological research
has focused on patients with existing PUs and a limitation
of the literature is the lack of evidence relating to the
extent of pain preceding PU development, the extent of
pain associated with Category 1 PUs (the most prevalent
PU Category) and the type of pain (i.e. inflammatory or
neuropathic). This study aims to determine the extent of
the problem in community populations.
There is a need to develop methods to assess localised
pain in pressure areas, including intact skin and Category
1. In order to describe pain in patient populations with
and without PUs four definitions were defined as follows:
1. Pressure area: a body site where PUs commonly
develop e.g. sacrum, heels
2. Pressure area related pain: pain on a pressure area
(see 1)
3. Pressure ulcer related pain: pain on a body site with
an observable PU
4. Unattributed pressure area related pain: pain
reported by the patient to be due to pressure on a
pressure area (see 1) but exact body site not specified.
A study by Briggs et al. [24] reported estimates of preva-
lence of such pain in hospital populations; they found an
overall unattributed pressure area related pain prevalence
of 16.3% which included a 12.6% unattributed pressure
area related pain prevalence in patients with no PUs and a
42.9% unattributed pressure area related pain prevalence
in patients with PUs in hospital populations. It is not
known whether the prevalence of pressure area related
and PU pain is similar in long term care settings such as
patients’ homes and care homes.
The current study investigates the prevalence of PU pain
in community populations. Hospital populations are more
accessible; the previous study [24] used detailed pain
questions with all patients whether they had a pressure
ulcer or not. Due to the practical limitations (time to visit
widespread geographical locations simultaneously) of the
current study, the detailed pain questions were only asked
of patients who had a PU and therefore has been reported
separately.
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comprise the Pressure UlceR Programme of ReSEarch
(PURPOSE), funded by the National Institute for
Health Research (NIHR,) which aims to reduce the impact
of PUs on patients through improved risk assessment and
the development of measures to capture patient reported
outcomes.
The primary aim of this study was to
 To estimate the prevalence of PU related pain
within a community population
The secondary objectives were
 To assess type and severity of PU pain
 To explore the association between pain and PU
classificationMethods
Study design
We undertook a cross sectional study in 2 community
NHS Sites in the north of England to establish PU pain
prevalence. Site 1 has a population of 259,536 of people
living in urban areas [25]. Site 2 has a population of
307,190 of people [26] with the majority living in rural
areas. Community NHS sites include patients in their
own homes, intermediate or long term care facilities
where some or all of the care is provided by the NHS. The
pain survey questions were nested into the routine annual
PU prevalence audits undertaken in the participating NHS
Trusts. The results of the PU prevalence audits have been
published by Stevenson et al. [14]. In addition to the
routine PU audit data, patients were asked two questions
relating to PU pain by community registered nurses, who
were trained in the data collection process, to establish
PU pain prevalence. The benefit of using the attending
community nursing teams was the ability to screen all
potential eligible patients, whilst also minimising burden
upon vulnerable patients. These advantages outweighed
the impact of multiple assessors upon reliability of data.The questions were
1. Do you currently have any pain, soreness, or
discomfort, either all the time or on and off in any
areas exposed to pressure (e.g. sacrum, buttocks, heels)?
2. Do you think your pain, soreness, or discomfort is
related to either your PU or pressure/rubbing due to
being in bed/chair?
These questions were adapted from the case screening
questions used in a large postal survey of pain prevalence
in the UK [27].Where pain was identified, consenting patients had a
detailed pain and skin assessment including pain severity,
type and Grade of PU by the Clinical Research Nurse.
Eligibility criteria
Patients over 18 years old and on community nursing
caseloads were eligible to be asked the two pain
questions when they had a PU assessed as a Grade
1,2,3,4 or Unstagable [28] and were considered well
and able to report the presence or absence of localised
pain. Paediatric, obstetric and psychiatric patients
were excluded. Patients were also excluded where it
was considered ethically or clinically inappropriate by
the community nursing team, for example, those
where death was imminent. Patients who replied ‘yes’
to both pain questions were then eligible for the detailed
pain assessment.
The Clinical Research Nurses were trained in study
procedures including pain assessment and skin assessments
by the Clinical Co-ordinator (LW) and the site Tissue
Viability Nurse Specialist. No formal inter-rater reliability
assessment was undertaken since previous research has
demonstrated high levels of agreement between specialist
nurses and clinical research nurses in skin assessment and
PU classification [29].
Data collection
Standard community practice for the PU prevalence
audit was used to assess and record data to ensure data
capture for the total population. The two sites applied
different eligibility criteria for PU case finding. Site 1
assessed all patients on the community nursing caseload,
patients in residential homes, rehabilitation units,
specialist palliative care units and all nursing homes in
the locality. Patients in site 1 were assessed whether they
were known to have a pressure ulcer or not. Site 2
assessed only patients on the community nursing caseload
in the locality who were known to have an existing PU.
Anonymised individual patient data were recorded by
community nurses who were trained in the data collection
process. Data recorded included location, date of birth,
gender, height, weight, mobility, risk assessment scale
(as per local policy) and PU classification by skin site
using the EPUAP classifications [28]. Unstagable PUs were
recorded as Grade U. Where another skin condition or
chronic wound was present on any of the key anatomical
skin sites (for example leg ulcer encroaching on a heel
area) these were also recorded.
The original (1998) EPUAP classification was used as
this was usual clinical practice in both community sites
at the time of the routine PU audits.
Where patients were assessed as unsuitable for the
pain screening question this was recorded along with the
reasons for ineligibility (see Figure 1). Patients assessed as
Figure 1 Participant flow.
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questions. Patients who answered yes to both questions
were then considered for recruitment to the detailed pain
study. Assenting patients were seen in their usual place of
residence by a Clinical Research Nurse who explained
the pain study and gained written or witnessed verbal
informed consent. The Clinical Research Nurse undertook
a full pain assessment and verification of skin status and
PU grade. Pain was assessed by asking patients to: report
the pain intensity (for most severe pain over the past
week) for all pressure area sites using a numerical ratingscale of 0–10 [30,31]; identify their most painful torso and
limb skin sites and these were assessed using the Leeds
Assessment Neuropathic Symptoms and Signs (LANSS)
Pain Scale [30].
The LANSS Scale is a clinically validated tool which
allows assessment of neuropathic and inflammatory
pain. It consists of a brief clinical assessment and is easy
to score in the clinical setting. The questionnaire contains
5 symptom items and 2 clinical sensory testing items
associated with neuropathic pain. The two skin sites
assessed using the LANSS included the most painful
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ischial tuberosities, hips) and the most painful site located
on a limb (e.g. heels, elbows) as reported by the patient.
Skin assessments undertaken by the community nurse for
the PU prevalence audit were verified through nursing
records or clinical assessment by the research nurse.
All data returned to the Clinical Trials Research Unit
for data processing was anonymous.
Analysis
Data were entered into a MACRO database; range
and consistency data checks were carried out to assess
accuracy of the data. Descriptive statistics were produced,
no inferential statistical testing were planned or under-
taken. Percentages were calculated using the total
number of patients from the relevant population as the
denominator (i.e. including all patients with missing data
for that variable). All analyses were carried out using SAS
software. All percentages were rounded to 1 decimal
place. Means, medians, standard deviations and ranges
were summarised to one more decimal place than the data
collected. The prevalence of pressure ulceration in the
population was calculated as a percentage as was the
overall proportion of patients reporting localised PU pain.
Ethical approval
The study was approved by the Leeds West Research
Ethics Committee (REC) prior to data collection.
Results
Site 1 collected data between 8th February and 2nd
April 2010 and Site 2 between 12th April and 7th May
2010. Figure 1 details the flow of participants through
each stage of the process.
The two community NHS Trusts identified 287 patients
with Grade 1-4/Unstagable pressure damage. The case
finding methods resulted in differing prevalence rates. In
site 1, 1680 patients were assessed and of these 185
patients were assessed as having a pressure ulcer Grade ≥1,
a prevalence rate of 0.77 per 1000 (185/240038)*1000
adults). In Site 2 102 patients were identified from the
community nursing caseloads and assessed as having a
Grade ≥1 pressure ulcer, a prevalence rate of 0.40 per 1000
((102/251891)*1000 adults).
The mean age of patients with pressure ulcers was
77.8 years (SD 13.44, range 23–106) with just over a third
men 34.8% (100/287), 84.3% (242/287) were assessed as ‘at
risk’ on either the Waterlow Score or Braden Scale and
only 1.4% (4/287) were non Caucasian (Table 1).
The 287 participants were reported to have 440 PUs
(mean 1.5 per patient, SD 0.83, range 1–5). Approximately a
third of PUs (155/440, 35.2%) were Grade 1, 40.2% (177/440)
were Grade 2 and 24.5% (108/440) were severe PUs.Primary aim
Two hundred and eighty seven patients with PUs were
identified and of these 176 (61.3%) were asked the pain
screening questions; Figure 1 gives reasons why the
remaining patients were unsuitable. The prevalence of
pressure ulcer related pain in the population of patients
with PUs who were asked the pain screening question
was 75.6% (133/176).
Demographic details for the three populations (all
patients with PUs, all those who reported pain and
those who consented to the detailed pain assessment)
are given in Table 1. Data on the number of PUs per
patient and the severity of their ulcers has been compared
for those who did and did not report pain. The informa-
tion on those with no pain is taken from the community
nurses data and was not confirmed by the clinical research
nurses as these patients were out with the study
population. This is presented in Table 2. This shows
similar severity and numbers of PUs per patient for
those with and without pain.
Secondary objectives
Of the 133 patients with unattributed pressure area
related pain, 96 were not able or declined to participate in
the full pain assessment (see Figure 1). Therefore, the
analysis population of eligible patients with unattributed
pressure area related pain who consented to the detailed
pain assessment was 27.8% (n = 37/133) of the population
reporting pain.
The mean age of these 37 patients was 72.6 years
(SD 15.31; range 23–98), most (70.3%) patients were
assessed in their own homes, the remainder were assessed
in residential or nursing homes, rehabilitation or palliative
care units. Twenty eight patients (75.7%) were female and
all were white British ethnic origin (see Table 1).
Pain and pressure ulcer classification
Pain was reported by patients with all grades of pressure
ulcers. It was reported in all but one Grade 1 PU with
most of the painful PU being at the sacrum, buttocks
and heels. Table 3 show the number of reports of pain
for each grade of PU.
Type of pain, severity of pressure ulcer and body site
A total of 481 skin sites were assessed (see Figure 2),
including 427 skin sites assessed as normal and 54 PUs
(mean 1.5 per patient; SD 0.65; range 1–3). Approximately
a third of PUs were Grade 1 (37.0%; n = 20/54), Grade 2
(31.5%; n = 17/54) and Grade 3/4/U (31.5%; n = 17/54)
(see Table 3), with 29 (53.7%) located on a torso skin site
and 25 (46.3%) located on a limb skin site.
The 37 patients reported pain on 53/481 (11.0%) skin
sites (median 1.0; mean 1.4; SD 0.65; range 1–3). No
pressure area related pain was reported on normal skin,
Table 1 Summary of demographics for total PU, pain and detailed assessment populations
Total community PU prevalence Pain prevalence population Detailed pain assessment population
Total Population 287 176 37
Age (in years):
Median 81.0 79.0 75.0
Mean (SD) 77.8 (13.44) 76.2 (13.27) 72.6 (15.31)
Range 23.0,106.0 23.0, 99.0 23.0, 98.0
Male 100 (34.8%) 71 (40.3%) 9 (24.3%)
n ‘at risk’ per RAS:
Waterlow 38/38 (100%) 16/16 (100%)
Braden 213/242(88.0%) 132/156 (84.6%) 25/37 (67.6%)
Non Caucasian 4 (1.4%) 2 (1.1%) 0 (0%)
Place of assessment:
Own home 134 (46.7%) 108 (61.4%) 26 (70.3%)
Nursing home 98 (34.1%) 44 (25.0%) 6 (16.2%)
Residential home 36 (12.5%) 10 (5.7%) 3 (8.1%)
Rehabilitation unit 12 (4.2%) 9 (5.1%) 1 (2.7%)
Specialist Palliative Care Unit 5 (1.7%) 4 (2.3%) 1 (2.7%)
Missing 2 (0.7%) 1 (0.6%) 0 (0.0%)
Total number of PUs 440 285 54
Number PU per patient
Median 1.0 1.0 1.0
Mean (SD) 1.5 (0.83) 1.6 (0.88) 1.5 (0.65)
Range 1.0, 5.0 1.0, 5.0 1.0, 3.0
Grade of PUs reported
Grade 1 155 (35.2%) 87 (30.5%) 20 (37.0%)
Grade 2 177 (40.2%) 118 (41.4%) 17 (31.5%)
Grade 3 63 (14.3%) 45 (15.8%) 8 (14.8%)
Grade 4 32 (7.3%) 25 (8.8%) 5 (9.3%)
Unstageable 13 (3.0%) 10 (3.5%) 4 (7.4%)
RAS = Risk Assessment Scale.
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all PUs (see Table 3). Pain intensity ranged from 1–10,
with a mean of 6.4 (SD 2.53) and median of 7.0. There is
a slightly skewed distribution of pain intensity with very
similar pain levels for each grade of PU (see Figure 3).
Thirty one patients identified one skin site for LANSS
assessment (n = 19 torso and n = 15 limb) and 6 patients
identified both a torso and limb site for LANSS assessment
providing a total of 22 torso and 18 limb LANSS
assessments. Neuropathic pain was slightly dominant in
both torso and limb skin sites, with 54.5% (n = 12/22) of
torso PUs and 61.1% (n = 11/18) of limb PUs scoring ≥12
on the LANSS assessment (see Table 4).
Discussion
This prevalence study was performed in a large community
population, using validated measures to assess the presenceof pressure area related pain and the intensity and type of
pain in people with pressure ulcers. Of the 176 patients
with pressure ulcers who were well and able to report pain
75.6% (133) reported unattributed pressure area pain. This
is similar to results of other smaller studies reporting
pressure ulcer pain prevalence ranging from 37% to 66%
and is comparable to the prevalence of pain in other
chronic wounds in European populations [31,32].
The detailed pain assessment of community patients
identified pressure area related pain on all Grades of
ulcer. The distribution of pain intensity measured using
a 0–10 nominal rating scale was similar for all grades,
which is consistent with pain intensity in other disease
states, where the severity of illness is not necessarily
related to patients’ reports of pain intensity [31]. It is
noteworthy that in the community patient population
none of the patients reported pressure area related pain
Figure 2 Flow diagram of detailed pain and skin assessments.
Table 2 PU characteristics for patients with and
without pain
Patients without
pain
Patients with
pain
Number of patients 43 133
Total number of PUs reported 70 215
Number of PUs
per patient
Mean (standard
deviation)
1.6 (0.90) 1.6 (0.88)
Median number
of PUs
1.0 1.0
Range (1.0, 5.0) (1.0, 4.0)
IQR (1.0, 2.0) (1.0, 2.0)
Grade 1 23 (32.9%) 64 (29.8%)
2 22 (31.4%) 96 (44.7%)
3 10 (14.3%) 35 (16.3%)
4 13 (18.6%) 12 (5.6%)
Unstagable 2 (2.9%) 8 (3.7%)
McGinnis et al. BMC Nursing 2014, 13:16 Page 7 of 10
http://www.biomedcentral.com/1472-6955/13/16on a skin site assessed as normal, whereas in our related
hospital pain prevalence patient population 12.6% of
patients without PUs reported pressure area related
pain [24].
In the community setting neuropathic pain was
dominant (54.5% torso and 61.1% limb). The proportion
of neuropathic pain observed is similar to the prevalence
of neuropathic pain in community leg ulcer patients
(43.5%) [31], but greater than the proportion observed
in our hospital pain prevalence patient population
(29.7% torso and 39.7% limb) [24]. We did not record
the duration of the pain or pressure ulcer and this may be
related to the type of pain and is an area of further study.
Limitations with the overall pain prevalence estimate
of unattributed pain are that: skin assessment data was
recorded by clinical staff which has inherent limitations
[4,29,33] and may have resulted in over or underreporting
of pressure ulcers or misclassification of Grade or extent of
tissue damage, particularly at Grade 1, which is prone
to misclassification [29]; As there were 85 Grade 1 ulcers,
however, this source of potential error must be acknowl-
edged. We were not able, due to resource constraints, toTable 3 Detailed pain assessment, number of times pain
reported by skin classification
Yes N (%) No N (%) Total N (%)
Normal skin 0 (0) 427 (100) 427(100)
Grade 1 19 (95.0) 1 (5.0) 20 (100.0)
Grade 2 17 (100.0) 0 (0.0) 17 (100.0)
Grade 3 8 (100.0) 0 (0.0) 8 (100.0)
Grade 4 5 (100.0) 0 (0.0) 5 (100.0)
Unstagable 4 (100.0) 0 (0.0) 4 (100.0)
Total 53 (11.0) 428 (89.0) 481 (100.0)have verification of grades by an independent assessor, and
we felt it too invasive/burdensome to record skin sites
photographically for remote checking. We were not able to
record pain treatment and therefore the quality of pain
management may differ between settings and impact upon
pain reports and the methodology used meant that a
significant proportion of patients (38.7%) were not able to
participate in the pain prevalence study due to illness
(too unwell, end of life, unconscious) or difficulty in
assessing (confused or communication difficulty).
The literature review by Peiper et al. [22] did not identify
any studies which used validated tools for neuropathic pain
assessment. Although the study by Quirono et al. [34]
identified pain descriptors for Category 1 PUs, none of the
other studies in the review considered Category 1 level
damage.
For the 37 patients whose severity of pressure damage
was confirmed by the Clinical research Nurse, all but
one was experiencing pain related to each of their ulcers.
Pain associated with PUs is also described in similar
studies of PUs in acute settings identifying 59% pain
prevalence [35], with 80% of participants reporting pain
for over 1 hour a day [34] and Briggs et al. [24] finding
43% of hospital patients with PUs, reporting pain.
The non-validated data suggests that pain occurs with
every grade of PU and that pain and no pain are broadly
comparable in terms of proportions at each grade. It
suggests that not all Grade 4 PUs are painful whereas
grade 1 can be painful. There does not appear to be an
association between the number of PUs and pain.
The detailed pain assessments identified that all but
one pressure ulcer was painful. This is inconsistent with
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Figure 3 Pain intensity by skin classification.
McGinnis et al. BMC Nursing 2014, 13:16 Page 8 of 10
http://www.biomedcentral.com/1472-6955/13/16the unverified data. Explanations for this could be that
those who do not report pain may have sensory impairment
e.g. spinal cord injury or have sufficient analgesia to mask
any pressure ulcer pain. It may be also be due to the small
sample size.
The greater proportion of reports of neuropathic
compared to inflammatory pain in the lower limbs
may be worthy of further exploration. The mechanisms
for neuropathic pain are not yet fully understood; it is
considered to be a heterogeneous group of conditions that
differ not only in aetiology but also location. A review byJensen et al. [36] states that one of the most common
locations for neuropathic pain is the peripheral nerves
however this is not informed by studies of pressure
ulcers. A study of painful leg ulceration by Briggs et al.
[31] identified that 43.5% of patients with lower limb
ulceration reported symptoms of neuropathic pain.
A limitation of this study is the small number of patients
who consented to the full pain and PU assessment. The
data in Table 2 suggests that 43 patients with no pain had
pressure damage, however this was not verified as only
those who consented to the full assessment has their PU
Table 4 Type of pain by skin classification for the most painful torso and limb areas
Location Skin classification Nociceptive N (%) Neuropathic N (%) Missing N (%) Total N (%)
Torso Grade 1 3 (42.9%) 4 (57.1%) 0 (0.0%) 7 (100.0%)
Grade 2 3 (33.3%) 6 (66.7%) 0 (0.0%) 9 (100.0%)
Grade 3 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 ( 0.0%)
Grade 4 4 (80.0%) 1 (20.0%) 0 (0.0%) 5 (100.0%)
Unstageable 0 (0.0%) 1 (100.0%) 0 (0.0%) 1 (100.0%)
Total# 10 (45.5%) 12 (54.5%) 0 (0.0%) 22 (100.0%)
Limb Grade 1 2 (50.0%) 2 (50.0%) 0 (0.0%) 4 (100.0%)
Grade 2 1 (20.0%) 4 (80.0%) 0 (0.0%) 5 (100.0%)
Grade 3 2 (33.3%) 3 (50.0%) 1 (16.7%) 6 (100.0%)
Grade 4 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Unstageable 1 (33.3%) 2 (66.7%) 0 (0.0%) 3 (100.0%)
Total$ 6 (33.3%) 11 (61.1%) 1 (5.6%) 18 (100.0%)
#The denominator here is the number of patients who completed the LANSS for a Torso skin site.
$The denominator here is the number of patients who completed the LANSS for a Limb skin site.
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in hospital patients, pain occurs at every grade including
those with no pressure damage and not all skin sites with
pressure damage were painful.
Figure 1 identified patients who were screened but
found to be unsuitable for the pain questions, of these,
half suffer confusion or experienced communication
difficulties, and 16% were too ill. In the UK inclusion
of patients who lack capacity has to be justified; the criter-
ion is that the research question cannot be answered with-
out them. As this was a first study, exploratory in nature,
the inclusion of patients who lacked capacity was not justi-
fied. Pressure ulcers are known to occur predominantly in
patients who are elderly or debilitate [14], the generalisabil-
ity of the findings in all PU populations is unknown.
The ability to feel pain and the levels of analgesia were
not reported in this study. Reporting both these variables
can be subjective, particularly in community settings
where access to medical records and prescriptions is
difficult. Levels of analgesia can be taken from patient
accounts, nursing records or observation of medications
in the home however it is likely that the actual medication
taken and the level of analgesia achieved vary in individual
patients. The ability to feel pain is also dependent on
co-morbidities e.g. spinal injury, stroke or diabetes,
again records of these may not be reliable in the patients
home. This study aimed to explore the association
between PUs and pain, the results suggest an association
in this sample of patients and it has provided useful
baseline data to inform future work.
The findings of this study have clinical relevance for
community nurses staff. It is likely that those patients who
have PUs will also be experiencing some degree of pain,
this needs to be recognised, assessed and management
plans implemented. It has been reported that pain canrestrict movement [34] which may increase the patients
risk of further pressure damage. Nurses also need to pay
heed to patients at risk of PUs who report pain as this may
be associated with unidentified pressure damage, a skin
assessment of the area exposed to pressure should follow.
Conclusion
This is the first study to report the prevalence of pain
associated with PUs in a UK community population, this
was found to be 75.6%. Of the patients who consented
to a detailed assessment of their PU and associated pain,
all reported pain at a PU site. In this small sample, areas
of the body with no pressure damage were found not to
be painful. Pain intensity was not related to number or
severity of ulcers. Both inflammatory and neuropathic
pain was identified in both limb and torso PUs, but neuro-
pathic pain was dominant. This study has contributed to
knowledge of pressure ulceration in community patients;
it will inform future studies. The identification of pain,
particularly in the early stages of PU development may be
a valuable clinical predictor of further pressure damage.
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